![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2020
Gross, Oliver; Toenshoff, Burkhard; Weber, Lutz T.; Pape, Lars; Latta, Kay; Fehrenbach, Henry; Lange-Sperandio, Baerbel; Zappel, Hildegard; Hoyer, Peter; Staude, Hagen; König, Sabine; John, Ulrike; Gellermann, Jutta; Hoppe, Bernd; Galiano, Matthias; Hoecker, Britta; Ehren, Rasmus; Lerch, Christian; Kashtan, Clifford E.; Harden, Markus; Boeckhaus, Jan und Friede, Tim
(2020):
A multicenter, randomized, placebo -controlled, double-blind phase 3 trial with open -arm comparison indicates safety and ef fi cacy of nephroprotective therapy with ramipril in children with Alport ? s syndrome see commentary.
In: Kidney International, Bd. 97, Nr. 6: S. 1275-1286
Boeckhaus, Jan; Hoefele, Julia; Riedhammer, Korbinian M.; Tonshoff, Burkhard; Ehren, Rasmus; Pape, Lars; Latta, Kay; Fehrenbach, Henry; Lange-Sperandio, Baerbel; Kettwig, Matthias; Hoyer, Peter; Staude, Hagen; Konrad, Martin; John, Ulrike; Gellermann, Jutta; Hoppe, Bernd; Galiano, Matthias; Gessner, Michaela; Pohl, Michael; Bergmann, Carsten; Friede, Tim und Gross, Oliver
(2020):
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial.
In: Clinical Genetics, Bd. 99, Nr. 1: S. 143-156
Weber, Lutz T.; Toenshoff, Burkhard; Grenda, Ryszard; Bouts, Antonia; Topaloglu, Rezan; Guelhan, Bora; Printza, Nikoleta; Awan, Atif; Battelino, Nina; Ehren, Rasmus; Hoyer, Peter F.; Novljan, Gregor; Marks, Stephen D.; Oh, Jun; Prytula, Agnieszka; Seeman, Tomas; Sweeney, Clodagh; Dello Strologo, Luca und Pape, Lars
(2020):
Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
In: Pediatric Transplantation, Bd. 25, Nr. 3, e13955
2019
Benz, Marcus R.; Ehren, Rasmus; Kleinert, Daniela; Müller, Carsten; Gellermann, Jutta; Fehrenbach, Henry; Schmidt, Heinrich und Weber, Lutz T.
(2019):
Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
In: Therapeutic Drug Monitoring, Bd. 41, Nr. 6: S. 696-702